This is a meeting of the Hemophilia Medical Advisory Panel (HMAP) formed to assist with the Agency’s Comprehensive Hemophilia Disease Management Programs. Business is to review the implementation of the Comprehensive Hemophilia Disease Management Program to date, discuss the procedures for clinical review of cases and guidelines, discuss any pending business, and to introduce new business. The purpose of HMAP is to develop clinical guidelines; review and recommend care protocols; suggest appropriate outreach methods to beneficiaries; review difficult cases and make recommendations.